.Novo Nordisk has axed its own once-monthly double GLP-1/ GIP receptor agonist, ending (PDF) develop...
.Merck & Co. has actually swiftly recouped a few of the expenses of its Spear Therapeutics buyout...
.After BioMarin performed a spring season clean of its own pipeline in April, the business has actua...
.Large Pharmas continue to be caught to the concept of molecular glue degraders. The most up to date...
.A brand-new global lifestyle scientific research credit history firm, dubbed Symbiotic Financing, h...
.Bristol Myers Squibb is actually axing yet another significant bet from the Caforio era, ending a b...
.After looking at phase 1 data, Nuvation Biography has determined to halt work on its single top BD2...
.Zevra Therapeutics' uncommon disease drug appears to be on the road to approval this fall after get...
.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has actually gone a $23...
.After greater than two decades of deal with neurodegenerative diseases, Swiss biotech a/c Immune sy...